Analysis of CD45+ peripheral blood leukocytes (PBLs) isolated from EO771 and 4T1-GFP tumor-bearing mice with tumors of similar size demonstrated that reserpine treatment prevented loss of IFNAR1 [Figure 6]. This evidence concerns the gene IFNAR1 and neoplasm.